Archives
-
Acetaminophen (Paracetamol) Research Guide
2026-09-29
Acetaminophen, also called paracetamol, is an antipyretic analgesic research compound associated with COX-2 activity, prostaglandin reduction, oxidative stress, and dose-dependent cell injury. This guide separates its pharmacology and hepatotoxicity research uses from the gene-silencing mechanisms investigated in transthyretin amyloid cardiomyopathy.
-
H3K18 Lactylation Drives Colorectal Cancer Progression
2026-09-28
The reference study identifies an H3K18 lactylation–METTL5–CCT2 pathway that connects lactate metabolism, epigenetic regulation, m6A-dependent RNA stability, and pyroptosis suppression in colorectal cancer. Its findings suggest that disrupting this axis, including through AZD6482 and oxaliplatin combination treatment, may offer a rationale for mechanistic and therapeutic investigation.
-
AO/PI Double Staining Kit: Practical Workflow
2026-09-28
The AO/PI Double Staining Kit uses Acridine Orange and Propidium Iodide to help distinguish green, membrane-intact cells from orange cells with condensed chromatin and red cells with compromised membranes. It is useful for rapid fluorescence-based cell viability assessment, but staining alone does not confirm a specific death pathway or replace orthogonal apoptosis testing.
-
EdU Imaging Kits (HF488): S-Phase Detection
2026-09-27
EdU Imaging Kits (HF488) detect DNA synthesis by labeling newly synthesized DNA with 5-ethynyl-2'-deoxyuridine and fluorescent click chemistry. The K2240 kit supports cell proliferation assay workflows using fluorescence microscopy or flow cytometry, while its signal should be interpreted as S-phase DNA synthesis rather than proof of completed cell division.
-
Cytosine Base Editing of BLG in Cattle
2026-09-26
A 2025 study used cytosine base editing to create a premature stop codon in the bovine β-lactoglobulin (BLG) gene, then assessed editing in embryos, mammary epithelial cells, and a live cow. The edited cow showed reduced BLG expression in mammary cells and milk, supporting further investigation of precision breeding for lower-BLG dairy products without establishing reduced allergenicity or clinical benefit.
-
Dehydroabietic acid: Workflows for Metabolic Research
2026-09-25
Use Dehydroabietic acid as a dual PPAR-α/γ agonist to investigate lipid metabolism regulation and insulin sensitivity in controlled cell-based assays. This guide pairs practical compound-handling advice with a clear distinction between established product information and hypotheses inspired by a separate triacetin metabolism study.
-
GPX4 and Platinum Resistance in Lung Cancer Brain Metastasis
2026-09-25
Liu and colleagues connect acquired platinum resistance in lung cancer-derived brain metastasis to increased glutathione consumption, GPX4 and GSTM1 activity, and suppression of ferroptosis. Their preclinical and mechanistic evidence places Wnt/NR2F2 signaling upstream of GPX4 expression, identifying a pathway for further study rather than an established clinical treatment strategy.
-
From Reporter Signal to Translational Mechanism
2026-09-24
Dual-reporter assays can connect transcription-factor hypotheses to measurable regulatory activity—but only when the signal is interpreted in the context of biological controls and orthogonal evidence. Using ZNF263–ULK1 research in intrahepatic cholangiocarcinoma as a case study, this article outlines a rigorous path from reporter design to translational insight.
-
Dual Luciferase Reporter Gene System in ICC Research
2026-09-24
See how the Dual Luciferase Assay System can test transcriptional hypotheses raised by ZNF263–ULK1 research, while a Renilla signal helps control for well-to-well variation. The practical guide covers reporter design, a pilot workflow, interpretation limits, and troubleshooting for mammalian cells.
-
Cholecystokinin Octapeptide Ammonium in Neuroscience
2026-09-23
Use Cholecystokinin octapeptide ammonium to test CCK1R-linked modulation of withdrawal-associated anxiety, with a notable reference study connecting the effect to endogenous opioids. This practical guide also covers dose selection, peptide-handling constraints, receptor controls, and limits on translating findings to other models.
-
Mithramycin A: A Translational Probe from DNA to Disease
2026-09-23
Mithramycin A is a metal-dependent G-C-rich DNA-binding anticancer antibiotic that connects transcriptional regulation, c-myc biology, and myeloid differentiation with a carefully bounded strategy for investigating the miR-24-3p/Sp1/PI3K axis in doxorubicin-related cardiac injury.
-
Benzyl-activated Streptavidin Magnetic Beads K1301
2026-09-22
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, peptides, antibodies, nucleic acids, sugars, and other targets from complex samples. They are suited to purification, immunoprecipitation, and interaction workflows, but nonbiotinylated targets require an indirect capture design and cell-based applications require removal or assessment of preservative residues.
-
Chrysin, NOX2, and Ferroptosis in Dry Eye
2026-09-22
Li and colleagues identify a mechanistic link between NOX2-driven oxidative stress, corneal epithelial ferroptosis, and STING/NLRP3-associated inflammation in dry eye. Their in vivo, in vitro, and transcriptomic design supports chrysin as a candidate intervention while also illustrating how orthogonal viability, oxidative-stress, and inflammatory measurements can strengthen ocular-surface research.
-
AO/PI Double Staining Kit: Practical Protocol
2026-09-21
The AO/PI Double Staining Kit provides a rapid fluorescent cell staining workflow for separating viable, apoptotic, and membrane-compromised cells in one sample. It is suitable for comparative cell viability assay work and preliminary apoptosis detection, but it should not be used alone to establish a death mechanism, absolute viability, or long-term reproductive capacity.
-
Biotinylated RNA and the Hidden Logic of m6A
2026-09-21
The emerging SMN–METTL14 connection shows that RNA modification homeostasis is shaped by protein methylation, disease-associated mutations, and genome-stability programs. This article translates that mechanistic insight into a practical strategy for using biotinylated RNA workflows to interrogate RNA–protein interactions without confusing label signal with m6A biology.